These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35999933)

  • 1. The Value of Sputum Polymerase Chain Reaction for Detection of Nontuberculous Mycobacteria in Cystic Fibrosis Patients with Negative Nontuberculous Mycobacteria Sputum Culture.
    Mirlohi SH; Eftekhari K; Shirzadi R; Fateh A; Masoumi M; Modaresi M
    Med J Islam Repub Iran; 2022; 36():7. PubMed ID: 35999933
    [No Abstract]   [Full Text] [Related]  

  • 2. Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.
    Breen P; Zimbric M; Opron K; Caverly LJ
    mSphere; 2022 Jun; 7(3):e0010422. PubMed ID: 35477313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.
    Whittier S; Olivier K; Gilligan P; Knowles M; Della-Latta P
    J Clin Microbiol; 1997 Oct; 35(10):2706-8. PubMed ID: 9316943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.
    Caverly LJ; Carmody LA; Haig SJ; Kotlarz N; Kalikin LM; Raskin L; LiPuma JJ
    PLoS One; 2016; 11(4):e0153876. PubMed ID: 27093603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.
    Preece CL; Wichelhaus TA; Perry A; Jones AL; Cummings SP; Perry JD; Hogardt M
    J Clin Microbiol; 2016 Jul; 54(7):1797-1803. PubMed ID: 27098962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
    Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
    BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
    Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
    BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
    Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.
    Bouso JM; Burns JJ; Amin R; Livingston FR; Elidemir O
    Pediatr Pulmonol; 2017 Mar; 52(3):324-330. PubMed ID: 28135043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics.
    Fowler SJ; French J; Screaton NJ; Foweraker J; Condliffe A; Haworth CS; Exley AR; Bilton D
    Eur Respir J; 2006 Dec; 28(6):1204-10. PubMed ID: 16807259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting
    Shin S; Yoo IY; Shim HJ; Kang OK; Jhun BW; Koh WJ; Huh HJ; Lee NY
    Ann Lab Med; 2020 Mar; 40(2):169-173. PubMed ID: 31650734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
    Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
    Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease.
    Hull RC; Huang JTJ; Barton AK; Keir HR; Ellis H; Cookson WOC; Moffatt MF; Loebinger MR; Chalmers JD
    Chest; 2022 May; 161(5):1180-1191. PubMed ID: 34838525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the long-term storage of sputum and the recovery of nontuberculous mycobacteria.
    Kwon BS; Park JS; Shin JA; Kim ES; Lim SY; Song MJ; Kim YW; Kim HJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Ther Adv Respir Dis; 2023; 17():17534666231162244. PubMed ID: 37070161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
    Low D; Wilson DA; Flume PA
    J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.
    De P; Amin AG; Graham B; Martiniano SL; Caceres SM; Poch KR; Jones MC; Saavedra MT; Malcolm KC; Nick JA; Chatterjee D
    J Cyst Fibros; 2020 Sep; 19(5):801-807. PubMed ID: 32624408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Mycobacterial Growth Indicator Tube with Culture on RGM Selective Agar for Detection of Mycobacteria in Sputum Samples from Patients with Cystic Fibrosis.
    Eltringham I; Pickering J; Gough H; Preece CL; Perry JD
    J Clin Microbiol; 2016 Aug; 54(8):2047-50. PubMed ID: 27225412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.
    Olivier KN; Weber DJ; Lee JH; Handler A; Tudor G; Molina PL; Tomashefski J; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):835-40. PubMed ID: 12433669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
    Calhoun KM; Armantrout E; Poch K; Caceres S; Lovell VK; Jones M; Malcolm KC; Vestal B; Wheeler E; Rysavy N; Manzer J; Aboellail I; Chatterjee D; Nick JA
    medRxiv; 2024 Aug; ():. PubMed ID: 39148848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors.
    Radhakrishnan DK; Yau Y; Corey M; Richardson S; Chedore P; Jamieson F; Dell SD
    Pediatr Pulmonol; 2009 Nov; 44(11):1100-6. PubMed ID: 19830845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.